Companion Animal Genomics & Diagnostics Market Forecasts to 2032 – Global Analysis By Disease Type (Infectious Diseases, Chronic Diseases, Cancer & Tumor Detection, Genetic Disorders, Endocrine Disorders, and Other Disease Types), Animal Type, Application
Description
According to Stratistics MRC, the Global Companion Animal Genomics & Diagnostics Market is accounted for $3.4 billion in 2025 and is expected to reach $6.2 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Companion Animal Genomics & Diagnostics is a field of veterinary science focused on the genetic analysis of pets. It involves sequencing and interpreting the DNA of dogs, cats, and other companion animals. This discipline identifies breed-specific composition, inherited disease predispositions, and unique genetic traits. Diagnostic applications use this genetic information to screen for hereditary conditions, confirm diagnoses, and understand the underlying molecular causes of diseases. It provides a scientific basis for understanding an individual animal's genetic health profile.
According to the American Veterinary Medical Association, advancements in genomic sequencing and molecular diagnostics are enabling earlier disease detection and personalized treatment approaches in companion animal healthcare.
Market Dynamics:
Driver:
Technological advancements in genetic testing
Technological advancements in genetic testing have revolutionized the Companion Animal Genomics & Diagnostics Market, enabling precise identification of hereditary conditions, disease predispositions, and breed verification. Innovations in DNA sequencing, biomarker analysis, and bioinformatics platforms allow veterinarians and pet owners to implement personalized healthcare strategies. These advancements enhance diagnostic accuracy, support preventive care, and facilitate early disease intervention. Integration of high-throughput sequencing, mobile reporting, and cloud-based analytics has expanded accessibility and usability, strengthening the market’s adoption across urban and rural veterinary practices globally.
Restraint:
High diagnostic and sequencing costs
High diagnostic and sequencing costs remain a significant restraint in the Companion Animal Genomics & Diagnostics Market, limiting adoption among cost-sensitive pet owners. Expensive testing procedures, laboratory fees, and proprietary platform charges reduce accessibility, particularly in emerging economies. This financial barrier can impede widespread implementation despite technological readiness. Additionally, recurrent testing for certain conditions or follow-ups increases cumulative costs. Market players must balance technological sophistication with affordability to ensure sustained growth and broader adoption across diverse pet owner demographics.
Opportunity:
Partnerships with veterinary telehealth platforms
Partnerships with veterinary telehealth platforms present a substantial growth opportunity in the Companion Animal Genomics & Diagnostics Market. Integrating genetic testing with virtual veterinary consultations enables remote diagnostics, personalized treatment plans, and early disease detection for pets. Such collaborations expand reach to underserved or rural areas, increase convenience for pet owners, and enhance engagement through digital platforms. Telehealth partnerships can also support subscription-based genomic monitoring, promoting continuous health management and driving recurring revenue streams for genomics service providers.
Threat:
Data privacy risks in genetic databases
Data privacy risks in genetic databases pose a notable threat to the Companion Animal Genomics & Diagnostics Market. Sensitive genomic information can be vulnerable to unauthorized access, cyberattacks, or misuse. Breaches may compromise pet owner confidentiality, undermine trust in service providers, and attract regulatory scrutiny. Maintaining secure storage, encryption protocols, and compliance with local and international data protection laws is critical. Failure to manage these risks effectively can impact adoption rates, hinder partnerships, and damage brand reputation in the competitive genomic diagnostics sector.
Covid-19 Impact:
The Covid-19 pandemic influenced the Companion Animal Genomics & Diagnostics Market by accelerating demand for at-home testing and telehealth services. Pet owners increasingly sought remote solutions for preventive care and genetic screening to reduce clinic visits. Laboratory operations adapted with digital reporting, contactless sample collection, and home delivery kits. However, supply chain disruptions and delayed sample processing temporarily impacted market activity. Overall, the pandemic highlighted the importance of remote diagnostic services and digital integration, reinforcing long-term growth prospects in companion animal genomics.
The infectious diseases segment is expected to be the largest during the forecast period
The infectious diseases segment is expected to account for the largest market share during the forecast period, accounting for a substantial share of the Companion Animal Genomics & Diagnostics Market. Testing for bacterial, viral, and parasitic infections enables early detection, accurate treatment, and improved animal welfare. Veterinary clinics and diagnostic laboratories prioritize infectious disease screening due to high prevalence and potential cross-species transmission. Integration with genetic profiling enhances preventive strategies, supports vaccination planning, and ensures targeted interventions, solidifying this segment as the primary contributor to overall market revenue over the coming years.
The dogs segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the dogs segment is predicted to witness the highest growth rate, propelled by increasing dog ownership, pet humanization, and rising awareness of breed-specific health conditions. Dog owners increasingly invest in genetic testing for disease prevention, ancestry tracking, and personalized nutrition. Advances in canine genomics, coupled with growing telehealth adoption, facilitate convenient and early diagnostic interventions. High consumer engagement and repeat testing potential make the dogs segment a critical driver of revenue growth, reflecting strong adoption trends across both developed and emerging markets.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to rapid urbanization, rising pet adoption rates, and increasing veterinary healthcare awareness. Countries like China, Japan, and India exhibit growing interest in advanced companion animal diagnostics. Expanding telehealth infrastructure, rising disposable incomes, and increasing digital literacy further enhance market penetration. Collectively, these factors establish the region as a dominant contributor to global market revenue, supporting growth in both urban and semi-urban veterinary diagnostics segments.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with advanced veterinary infrastructure, high pet ownership, and strong adoption of genomic technologies. The United States and Canada benefit from widespread telehealth platforms, veterinary network integration, and technological readiness. High consumer spending on preventive care and personalized pet health solutions further accelerates market growth. These conditions, combined with supportive regulatory frameworks and innovation-driven genomics companies, position North America as the fastest-growing regional market in companion animal genomics and diagnostics.
Key players in the market
Some of the key players in Companion Animal Genomics & Diagnostics Market include Mars Petcare, Embark Veterinary, Zoetis, IDEXX Laboratories, Basepaws, Neogen, Orivet Genetic Pet Care, Paw Print Genetics, VetGen, Animal Genetics Inc., UC Davis Veterinary Genetics Laboratory, Genoscoper, EasyDNA, Heska Corporation, Genetic Veterinary Sciences, Virbac, Nestlé Purina, and Royal Canin.
Key Developments:
In August 2025, Embark Veterinary announced the new ""Breed + Health Kit"" with expanded screening for over 250 genetic health conditions and traits in dogs, providing breeders and owners with more comprehensive hereditary disease risk reports.
In July 2025, Zoetis launched the new Vetscan Imagyst® platform with integrated genomic analysis, designed to combine AI-powered digital cytology with genetic testing for streamlined in-clinic diagnostic workflows for companion animals.
In June 2025, IDEXX Laboratories announced the launch of its ""Make in India"" initiative for the IDEXX Genetic Intelligence Panel to support the expansion of affordable, localized premium diagnostic services for pets across the region.
Disease Types Covered:
• Infectious Diseases
• Chronic Diseases
• Cancer & Tumor Detection
• Genetic Disorders
• Endocrine Disorders
• Other Disease Types
Animal Types Covered:
• Dogs
• Cats
• Horses
• Other Animal Types
Applications Covered:
• Clinical Pathology
• Toxicology
• Bacteriology
• Parasitology
• Pregnancy Testing
• Other Applications
End Users Covered:
• Veterinary Hospitals & Clinics
• Diagnostic Laboratories
• Research Institutions
• Point-of-Care Testing
• Home Care
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
According to the American Veterinary Medical Association, advancements in genomic sequencing and molecular diagnostics are enabling earlier disease detection and personalized treatment approaches in companion animal healthcare.
Market Dynamics:
Driver:
Technological advancements in genetic testing
Technological advancements in genetic testing have revolutionized the Companion Animal Genomics & Diagnostics Market, enabling precise identification of hereditary conditions, disease predispositions, and breed verification. Innovations in DNA sequencing, biomarker analysis, and bioinformatics platforms allow veterinarians and pet owners to implement personalized healthcare strategies. These advancements enhance diagnostic accuracy, support preventive care, and facilitate early disease intervention. Integration of high-throughput sequencing, mobile reporting, and cloud-based analytics has expanded accessibility and usability, strengthening the market’s adoption across urban and rural veterinary practices globally.
Restraint:
High diagnostic and sequencing costs
High diagnostic and sequencing costs remain a significant restraint in the Companion Animal Genomics & Diagnostics Market, limiting adoption among cost-sensitive pet owners. Expensive testing procedures, laboratory fees, and proprietary platform charges reduce accessibility, particularly in emerging economies. This financial barrier can impede widespread implementation despite technological readiness. Additionally, recurrent testing for certain conditions or follow-ups increases cumulative costs. Market players must balance technological sophistication with affordability to ensure sustained growth and broader adoption across diverse pet owner demographics.
Opportunity:
Partnerships with veterinary telehealth platforms
Partnerships with veterinary telehealth platforms present a substantial growth opportunity in the Companion Animal Genomics & Diagnostics Market. Integrating genetic testing with virtual veterinary consultations enables remote diagnostics, personalized treatment plans, and early disease detection for pets. Such collaborations expand reach to underserved or rural areas, increase convenience for pet owners, and enhance engagement through digital platforms. Telehealth partnerships can also support subscription-based genomic monitoring, promoting continuous health management and driving recurring revenue streams for genomics service providers.
Threat:
Data privacy risks in genetic databases
Data privacy risks in genetic databases pose a notable threat to the Companion Animal Genomics & Diagnostics Market. Sensitive genomic information can be vulnerable to unauthorized access, cyberattacks, or misuse. Breaches may compromise pet owner confidentiality, undermine trust in service providers, and attract regulatory scrutiny. Maintaining secure storage, encryption protocols, and compliance with local and international data protection laws is critical. Failure to manage these risks effectively can impact adoption rates, hinder partnerships, and damage brand reputation in the competitive genomic diagnostics sector.
Covid-19 Impact:
The Covid-19 pandemic influenced the Companion Animal Genomics & Diagnostics Market by accelerating demand for at-home testing and telehealth services. Pet owners increasingly sought remote solutions for preventive care and genetic screening to reduce clinic visits. Laboratory operations adapted with digital reporting, contactless sample collection, and home delivery kits. However, supply chain disruptions and delayed sample processing temporarily impacted market activity. Overall, the pandemic highlighted the importance of remote diagnostic services and digital integration, reinforcing long-term growth prospects in companion animal genomics.
The infectious diseases segment is expected to be the largest during the forecast period
The infectious diseases segment is expected to account for the largest market share during the forecast period, accounting for a substantial share of the Companion Animal Genomics & Diagnostics Market. Testing for bacterial, viral, and parasitic infections enables early detection, accurate treatment, and improved animal welfare. Veterinary clinics and diagnostic laboratories prioritize infectious disease screening due to high prevalence and potential cross-species transmission. Integration with genetic profiling enhances preventive strategies, supports vaccination planning, and ensures targeted interventions, solidifying this segment as the primary contributor to overall market revenue over the coming years.
The dogs segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the dogs segment is predicted to witness the highest growth rate, propelled by increasing dog ownership, pet humanization, and rising awareness of breed-specific health conditions. Dog owners increasingly invest in genetic testing for disease prevention, ancestry tracking, and personalized nutrition. Advances in canine genomics, coupled with growing telehealth adoption, facilitate convenient and early diagnostic interventions. High consumer engagement and repeat testing potential make the dogs segment a critical driver of revenue growth, reflecting strong adoption trends across both developed and emerging markets.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to rapid urbanization, rising pet adoption rates, and increasing veterinary healthcare awareness. Countries like China, Japan, and India exhibit growing interest in advanced companion animal diagnostics. Expanding telehealth infrastructure, rising disposable incomes, and increasing digital literacy further enhance market penetration. Collectively, these factors establish the region as a dominant contributor to global market revenue, supporting growth in both urban and semi-urban veterinary diagnostics segments.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with advanced veterinary infrastructure, high pet ownership, and strong adoption of genomic technologies. The United States and Canada benefit from widespread telehealth platforms, veterinary network integration, and technological readiness. High consumer spending on preventive care and personalized pet health solutions further accelerates market growth. These conditions, combined with supportive regulatory frameworks and innovation-driven genomics companies, position North America as the fastest-growing regional market in companion animal genomics and diagnostics.
Key players in the market
Some of the key players in Companion Animal Genomics & Diagnostics Market include Mars Petcare, Embark Veterinary, Zoetis, IDEXX Laboratories, Basepaws, Neogen, Orivet Genetic Pet Care, Paw Print Genetics, VetGen, Animal Genetics Inc., UC Davis Veterinary Genetics Laboratory, Genoscoper, EasyDNA, Heska Corporation, Genetic Veterinary Sciences, Virbac, Nestlé Purina, and Royal Canin.
Key Developments:
In August 2025, Embark Veterinary announced the new ""Breed + Health Kit"" with expanded screening for over 250 genetic health conditions and traits in dogs, providing breeders and owners with more comprehensive hereditary disease risk reports.
In July 2025, Zoetis launched the new Vetscan Imagyst® platform with integrated genomic analysis, designed to combine AI-powered digital cytology with genetic testing for streamlined in-clinic diagnostic workflows for companion animals.
In June 2025, IDEXX Laboratories announced the launch of its ""Make in India"" initiative for the IDEXX Genetic Intelligence Panel to support the expansion of affordable, localized premium diagnostic services for pets across the region.
Disease Types Covered:
• Infectious Diseases
• Chronic Diseases
• Cancer & Tumor Detection
• Genetic Disorders
• Endocrine Disorders
• Other Disease Types
Animal Types Covered:
• Dogs
• Cats
• Horses
• Other Animal Types
Applications Covered:
• Clinical Pathology
• Toxicology
• Bacteriology
• Parasitology
• Pregnancy Testing
• Other Applications
End Users Covered:
• Veterinary Hospitals & Clinics
• Diagnostic Laboratories
• Research Institutions
• Point-of-Care Testing
• Home Care
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Table of Contents
200 Pages
- 1 Executive Summary
- 2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
- 3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Application Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
- 4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
- 5 Global Companion Animal Genomics & Diagnostics Market, By Disease Type
- 5.1 Introduction
- 5.2 Infectious Diseases
- 5.3 Chronic Diseases
- 5.4 Cancer & Tumor Detection
- 5.5 Genetic Disorders
- 5.6 Endocrine Disorders
- 5.7 Other Disease Types
- 6 Global Companion Animal Genomics & Diagnostics Market, By Animal Type
- 6.1 Introduction
- 6.2 Dogs
- 6.3 Cats
- 6.4 Horses
- 6.5 Other Animal Types
- 7 Global Companion Animal Genomics & Diagnostics Market, By Application
- 7.1 Introduction
- 7.2 Clinical Pathology
- 7.3 Toxicology
- 7.4 Bacteriology
- 7.5 Parasitology
- 7.6 Pregnancy Testing
- 7.7 Other Applications
- 8 Global Companion Animal Genomics & Diagnostics Market, By End User
- 8.1 Introduction
- 8.2 Veterinary Hospitals & Clinics
- 8.3 Diagnostic Laboratories
- 8.4 Research Institutions
- 8.5 Point-of-Care Testing
- 8.6 Home Care
- 9 Global Companion Animal Genomics & Diagnostics Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
- 10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
- 11 Company Profiling
- 11.1 Mars Petcare
- 11.2 Embark Veterinary
- 11.3 Zoetis
- 11.4 IDEXX Laboratories
- 11.5 Basepaws
- 11.6 Neogen
- 11.7 Orivet Genetic Pet Care
- 11.8 Paw Print Genetics
- 11.9 VetGen
- 11.10 Animal Genetics Inc.
- 11.11 UC Davis Veterinary Genetics Laboratory
- 11.12 Genoscoper
- 11.13 EasyDNA
- 11.14 Heska Corporation
- 11.15 Genetic Veterinary Sciences
- 11.16 Virbac
- 11.17 Nestlé Purina
- 11.18 Royal Canin
- List of Tables
- Table 1 Global Companion Animal Genomics & Diagnostics Market Outlook, By Region (2024-2032) ($MN)
- Table 2 Global Companion Animal Genomics & Diagnostics Market Outlook, By Disease Type (2024-2032) ($MN)
- Table 3 Global Companion Animal Genomics & Diagnostics Market Outlook, By Infectious Diseases (2024-2032) ($MN)
- Table 4 Global Companion Animal Genomics & Diagnostics Market Outlook, By Chronic Diseases (2024-2032) ($MN)
- Table 5 Global Companion Animal Genomics & Diagnostics Market Outlook, By Cancer & Tumor Detection (2024-2032) ($MN)
- Table 6 Global Companion Animal Genomics & Diagnostics Market Outlook, By Genetic Disorders (2024-2032) ($MN)
- Table 7 Global Companion Animal Genomics & Diagnostics Market Outlook, By Endocrine Disorders (2024-2032) ($MN)
- Table 8 Global Companion Animal Genomics & Diagnostics Market Outlook, By Other Disease Types (2024-2032) ($MN)
- Table 9 Global Companion Animal Genomics & Diagnostics Market Outlook, By Animal Type (2024-2032) ($MN)
- Table 10 Global Companion Animal Genomics & Diagnostics Market Outlook, By Dogs (2024-2032) ($MN)
- Table 11 Global Companion Animal Genomics & Diagnostics Market Outlook, By Cats (2024-2032) ($MN)
- Table 12 Global Companion Animal Genomics & Diagnostics Market Outlook, By Horses (2024-2032) ($MN)
- Table 13 Global Companion Animal Genomics & Diagnostics Market Outlook, By Other Animal Types (2024-2032) ($MN)
- Table 14 Global Companion Animal Genomics & Diagnostics Market Outlook, By Application (2024-2032) ($MN)
- Table 15 Global Companion Animal Genomics & Diagnostics Market Outlook, By Clinical Pathology (2024-2032) ($MN)
- Table 16 Global Companion Animal Genomics & Diagnostics Market Outlook, By Toxicology (2024-2032) ($MN)
- Table 17 Global Companion Animal Genomics & Diagnostics Market Outlook, By Bacteriology (2024-2032) ($MN)
- Table 18 Global Companion Animal Genomics & Diagnostics Market Outlook, By Parasitology (2024-2032) ($MN)
- Table 19 Global Companion Animal Genomics & Diagnostics Market Outlook, By Pregnancy Testing (2024-2032) ($MN)
- Table 20 Global Companion Animal Genomics & Diagnostics Market Outlook, By Other Applications (2024-2032) ($MN)
- Table 21 Global Companion Animal Genomics & Diagnostics Market Outlook, By End User (2024-2032) ($MN)
- Table 22 Global Companion Animal Genomics & Diagnostics Market Outlook, By Veterinary Hospitals & Clinics (2024-2032) ($MN)
- Table 23 Global Companion Animal Genomics & Diagnostics Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
- Table 24 Global Companion Animal Genomics & Diagnostics Market Outlook, By Research Institutions (2024-2032) ($MN)
- Table 25 Global Companion Animal Genomics & Diagnostics Market Outlook, By Point-of-Care Testing (2024-2032) ($MN)
- Table 26 Global Companion Animal Genomics & Diagnostics Market Outlook, By Home Care (2024-2032) ($MN)
- Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
